ArticleThe Pan African medical journal2022
[Socio-demographic and economic profile of adult patients with sickle cell disease followed up on a regular basis at the University Hospital Center of Libreville].
Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease is a genetic disease transmitted as an autosomal recessive trait. Since September 2016, at the University Hospital Center of Libreville (UHCL) hematology consultation dedicated to adult patients with sickle cell disease was offered. This was the occasion to conduct this study, the purpose of which was to describe the socio-demographic and economic profile of patients followed up on a regular basis. We conducted a retrospective, descriptive and non-comparative study in the Department of Internal Medicine at the UHCL, from September 2016 to June 2019. Patients aged 18 years and older with homozygous sickle cell disease who had been followed up during the study period, were able to answer questions and had undergone at least three haematology consultations were included in the study. A total of 88 patients out of 233 met the inclusion criteria during the study period; women predominated. The sex ratio was 0.5 and the average age of patients was 30.4 ± 7.8 years, 42% had a higher education level, 88.6% had health insurance that allowed 31.8% of them to take care of themselves, in addition to their monthly income. Sickle cell disease was an obstacle in patients daily and professional lives but they got support from family and friends. This study shows that patients with sickle cell disease who attend follow-up visits are integrated into society. Most of them have an education level that allow them to understand their illness and a health insurance which can help them manage their illness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.